Genetic Biomarkers Associated With Child Language Development in Taiwan (II)
1 other identifier
observational
115
1 country
1
Brief Summary
A study of the relation between genetic biomarkers and child language development in Taiwan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedFirst Submitted
Initial submission to the registry
August 19, 2022
CompletedFirst Posted
Study publicly available on registry
August 22, 2022
CompletedAugust 28, 2024
August 1, 2022
12 months
August 19, 2022
August 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Scores of cognitive function 1
Bayley Scales of Infant and Toddler Development (Scores from 0 to 140, higher scores mean a better outcome.)
baseline
Scores of cognitive function (2 y/o to 6 y/o)
Wechsler Preschool and Primary Scale of Intelligence (Scores from 0 to 200, higher scores mean a better outcome.)
baseline
Scores of cognitive function (6 y/o to 16 y/o)
Wechsler Intelligence Scale for Children (Scores from 0 to 200, higher scores mean a better outcome.)
baseline
Scores of cognitive function 3
Test of Nonverbal Intelligence-Fourth Edition (Scores from 0 to 60, higher scores mean a better outcome.)
baseline
Scores of language function 1
Peabody Picture Vocabulary Test-Revised (Scores from 0 to 124, higher scores mean a better outcome.)
baseline
Scores of language function 2
Preschool Language Impaired Scale(PLS)/Language Impaired Scale(LS) (PLS: Scores from 0 to 65, higher scores mean a better outcome. LS: Scores from 0 to 73, higher scores mean a better outcome.)
baseline
Scores of general development
Comprehensive Developmental Inventory for Infants and Toddlers (Higher scores mean a better outcome.) Applied for children aged 3-71 months. Assessing areas: Cognition, language, motor, social, and self-care skills. Every item is scored 0 or 1, indicating whether the child 'fails' or 'passess' that item.
baseline
Gene test 1
Microarray (Use Axiom Genome-Wide TWB 2.0 Array Plate (TWB 2.0) to analyze SNPs of disease-related biomarkers.)
baseline
Gene test 2
Whole-Exome Sequencing (Use Burrows-Wheeler Aligner (BWA) 85, Samtools86, Picard, Genome Analysis Toolkit (GATK) to screen out the variant discovery and genotyping.)
baseline
Secondary Outcomes (4)
Scores of participation(2-5 y/o)
baseline
Scores of participation(>6 y/o)
baseline
Scores of activities
baseline
Scores of quality of life
baseline
Study Arms (2)
control
healthy child
experimental
patients with language disorder
Interventions
We use Whole-exome sequence (WES) to analyze if there is any gene mutations for DLD(developmental language disorder) children.
Eligibility Criteria
Control and experimental groups
You may qualify if:
- Age 2-18 y/o
- Agree to sign informed consent
You may not qualify if:
- Central nervous system disease
- Neuromuscular Disorders
- Congenital Abnormality
- Genetic Disease
- Dysesthesia
- Hearing Impairment
- Patients with Language Disorder
- Age 2-18 y/o
- Agree to sign informed consent
- Hearing Impairment
- His or her child participated in this study, and gene abnormality was found.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung Memoria Hospital
Taoyuan District, Taiwan
Biospecimen
samples with DNA
Study Officials
- STUDY DIRECTOR
Chia-Ling Chen, MD, PhD
Chang Gung Memorial Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2022
First Posted
August 22, 2022
Study Start
August 2, 2021
Primary Completion
July 31, 2022
Study Completion
July 31, 2022
Last Updated
August 28, 2024
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share